Drake JM, Graham NA, Lee JK, Stoyanova T, Faltermeier CM, Sud S et al (2013) Metastatic
castration-resistant prostate cancer reveals intrapatient similarity and intrapatient heterogene-
ity of therapeutic kinase targets. Proc Natl Acad Sci U S A 110:E4762–E4769
Edwards AVG, White MY, Cordwell SJ (2008) The role of proteomics in clinical cardiovascular
biomarker discovery. Mol Cell Proteomics 7:1824–1837
Eller M, Williams DR (2009) Biological fluid biomarkers in neurodegenerative Parkinsonism.
Nat Rev Neurol 5:561–570
Erben P, Horisberger K, Muessle B, M€uller MC, Treschl A, Ernst T (2008) mRNA expression of
platelet-derived growth factor receptor-beta and C-KIT: correlation with pathologic response
to cetuximab-based chemoradiotherapy in patient with rectal cancer. Int J Radiat Oncol Biol
Phys 72:1544–1550
Farrah T, Deutsch EW, Hoopmann MR, Hallows JL, Sun Z, Huang CY, Moritz RL (2013) The
state of the human proteome in 2012 as viewed through Peptide Atlas. J Proteome Res 12:
162–171
Forler S, Klein D, Klose J (2014) Individualized proteomics. J Proteomics 107:56–61
Forsstr€om B, Bisławska Axna ̈s B, Stengele K-P, B€uhler J, Albert TJ et al (2014) Proteome-wide
epitope mapping of antibodies using ultra-dense peptide arrays. Mol Cell Proteomics 13:
1585–1597
Fredolini C, Liotte L, Petricoin EF (2011) Application of proteomic technologies for prostate
cancer detection, prognosis and tailored therapy. Crit Rev Clin Lab Sci 47:125–136
Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E et al (2012) Intratumor
heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:
883–892
Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P et al (2011) Genome wide association study identi-
fies susceptibility loci for IgA nephropathy. Nat Genet 43:321–327
Glauber HS, Rishe N, Karnieli E (2014) Introduction to personalized medicine in diabetes mellitus.
Rambam Maimonides Med J 5(1), e0002. doi:10.5041/RMMJ.10136
Goh HI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL (2007) The human disease network.
Proc Natl Acad Sci U S A 104:8685–8690
Goldknopf IL (2008) Blood-based proteomics for personalized medicine: examples from neuro-
degenerative disease. Exp Rev Proteomics 5:1–8
Grollman A, Shibutani S, Moriya M, Miller F, Wu L et al (2007) Aristolochic acid in the etiology of
endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A 104:12129–12134
Grubb RL, Deng J, Pinto PA, Mohler JL, Chinnaiyan A, Rubin M et al (2009) Pathway biomarker
profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic
signatures. J Proteome Res 8:3044–3054
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA et al (1983) A polymorphic
DNA marker genetically linked to Huntington’s disease. Nature 306:234–238
Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R (2000) Evaluation of two-dimensional
gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci 97:9390–9395
Halim A, Carlsson MC, Madsen CB, Brand S, Møller SR et al (2014) Glycoproteomic analysis of
seven major allergenic proteins reveals novel post-translational modifications. Mol Cell Pro-
teomics. doi:10.1074/mcp.M114.042614
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A et al (2009) Genome-wide association
study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet
41:1088–1093
Harris GA, Nicklay JJ, Caprioli RM (2013) Localizedin situhydrogel-mediated protein digestion
and extraction technique for on-tissue analysis. Anal Chem 85:2717–2723
Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease
pathogenesis. Nat Clin Pract 4:600–609
Hodgin JB, Cohen CD (2010) Experimental approaches to the human renal transcriptome.
Semin Nephrol 30:455–457
The Role of Proteomics in Personalized Medicine 213